MedTrace Logo

Effects of Early Short-term Intravenous Iron Supplements Combined EPO in Preterm Infants

NCT02060851 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2020-02-25

No results posted yet for this study

Summary

There are wide variations in iron supplementation practices in NICU.Guidelines on pediatric Parenteral nutrition suggested the dose of 200μg/kg.d iron by parenteral nutrition.

Conditions

  • Malnutrition

Interventions

OTHER

standard PN

Group 1: a control group who received standard PN

DRUG

Vifor

iron sucrose, 200 μg/kg per day, was given everyday with PN,

DRUG

Vifor and EPO

EPO, 400U/kg, was given twice a week (Monday and Friday). IS, 200 μg/kg per day, was given everyday with PN, and the dose was continued until 2 weeks after birth

Sponsors & Collaborators

  • Kunshan First People's Hospital Affiliated to Jiangsu University

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Max Age
24 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02060851 on ClinicalTrials.gov